A site-specific cross-linking approach was used to study the integration of TM (transmembrane) segments 4-7 of the polytopic membrane protein, opsin, at the ER (endoplasmic reticulum). We found that although TM4 exits the ER translocon rapidly, TM segments 5, 6 and 7 are all retained at the translocon until opsin biosynthesis is terminated. Furthermore, although artificial extension of the nascent chain is not sufficient to release the C-terminal region of opsin from the translocon, substitution of the native TM segment 7 with a more hydrophobic TM segment results in its rapid lateral exit into the lipid bilayer. We conclude that the intrinsic properties of a TM segment determine the timing of its membrane integration rather than its relative location within the polypeptide chain. A pronounced and prolonged association of opsin TM5 with the translocon-associated component PAT-10 was also observed, suggesting that PAT-10 may facilitate the assembly of distinct opsin subdomains during membrane integration. The results of the present study strongly support a model in which the ER translocon co-ordinates the integration of selected TM segments in response to the specific requirements of the precursor being synthesized.
INTRODUCTION
A crucial step in the biogenesis of integral membrane proteins is their incorporation into the hydrophobic environment of the lipid bilayer [1, 2] . In eukaryotic cells this event frequently occurs co-translationally at the Sec61 translocon of the ER (endoplasmic reticulum), a site that also mediates the complete translocation of soluble proteins into the ER lumen where conditions are optimized for folding and maturation [1] [2] [3] . The core of the ER translocon comprises a heterotrimer of Sec61α, β and γ subunits [4] . High-resolution structural studies of a related archeal translocon indicate that protein translocation may occur through a narrow pore formed by a single Sec61 heterotrimer [5] . In this model, a translocation pore of ∼ 5-8 Å (1 Å = 0.1 nm) in diameter would be gated by a subdomain of the Sec61α subunit [5] . Although deletion of this putative 'plug' in both the yeast and bacterial homologues causes only minor defects in co-translational translocation [6, 7] , it has been suggested that replacement plug structures may be formed in these deletion mutants [8] . A structural model of the eubacterial SecYEG translocon, captured with a bound ribosome-nascent chain complex, suggests that two heterotrimers may act in concert to form a larger translocation pore through the membrane [9] . Likewise, cross-linking data from purified bacterial SecY complexes reconstituted into proteoliposomes supports a model in which oligomerization of the core SecYEG heterotrimer facilitates the formation of an active translocation channel [10] . Thus although the translocation pore itself may be formed by just one Sec61 heterotrimer, it is likely that multiple copies are required for translocation to occur [11] [12] [13] . Subsidiary translocon components, such as the TRAM (translocating chain-associated membrane) protein and PAT-10 (a protein associated with the ER translocon of 10 kDa), are proposed to have specialized functions during protein biosynthesis at the ER, although their roles are yet to be fully defined [14] [15] [16] [17] .
The hydrophobic TM (transmembrane) segments present in membrane proteins appear to engage the ER translocon and then enter the lipid bilayer, presumably via a 'lateral gate' separating the aqueous translocation pore from the hydrophobic membrane phase [17, 18] . This 'partitioning' of TM segments into the lipid bilayer during translocation has been studied in some detail for simple, single-spanning membrane proteins [14, 15, 18, 19] . However, polytopic membrane protein integration presents additional problems, since multiple TM segments must be integrated and correctly assembled [1, 2] . Studies to date suggest that the integration of polytopic proteins is influenced by multiple factors, including: net hydrophobicity of a TM span [15, 20] , TM segment interactions [21, 22] and the length of soluble loop domains connecting TM regions [23] . In the case of polytopic proteins such as bacterioopsin and AQP (aquaporin) 4, studies to date suggest TM integration occurs sequentially as each new TM segment is synthesized by the ribosome [16, [24] [25] [26] [27] . However, the fate of TM segments following initial engagement with the ER translocon can vary depending on the precursor, for example the synthesis of a new TM segment may not necessarily lead to the complete release of the preceding TM segment from the Sec61 complex. Hence, in the case of opsin, TM1 is 'parked' at a distinct Sec61 location after initial integration at the translocon core [16, 24] , and a similar phenomenon is observed for multiple TM segments within AQP4 [26] . Thus, for the limited number of polytopic membrane proteins studied to date, the integration process appears remarkably complex [17, 24, 26] .
Both TM segments and soluble loop regions of complex polytopic membrane proteins must be correctly assembled to generate a functional conformation and these processes may be linked. Hence, in the case of the CFTR (cystic fibrosis transmembrane conductance regulator) protein, the correct folding of the first ATP-binding domain present in a large intracellular loop is dependent on the assembly of preceding membrane-spanning segments [28] . Similarly, intramembrane assembly of AQP1 is dependent on close intra-and inter-molecular bonding between TM segments [22] . For AQP1, these interactions are dependent on highly polar residues within the TM segments that compromise hydrophobicity but appear necessary to achieve a correctly folded and functional protein structure.
We selected opsin as a model polytopic protein for the study of membrane integration at the ER [25] , and established the use of site-specific chemical cross-linking as a valid approach to report the proteinaceous environment of individual TM segments [16] . To date we have analysed the behaviour of opsin TM segments 1-3 and carefully mapped their lateral exit from the ER translocon [16, 24] . These studies revealed that different TM segments associate with distinct translocon components [16] and can exit the translocon by distinct mechanisms [24] , but did not address the integration of opsin TM segments 4-7. In the present study, we have specifically investigated the biosynthesis of the Cterminal region of opsin in order to complete our previous studies and provide a full molecular description of its integration [16, 24] . We show that although opsin TM4 is integrated into the lipid bilayer following the synthesis of TM5, TM segments 5, 6 and 7 all remain in close proximity to the ER translocon throughout opsin biosynthesis. Remarkably, extending the cytosolic C-terminal tail of opsin does not release these TM segments from the translocon, indicating that TM segments 5-7 are not simply 'tethered' to the Sec61 complex. However, by replacing opsin TM7 with a different TM segment, rapid exit from the ER translocon can be achieved. The distinctive behaviour of TM7 at the ER translocon, together with the selective adduct formation between the opsin nascent chain and PAT-10, leads us to propose that the retention of the C-terminal TM segments of opsin at the Sec61 translocon reflects substrate-specific assembly requirements. We incorporate this hypothesis into a unifying model for opsin biogenesis.
MATERIALS AND METHODS

Reagents
T7 RNA polymerase, transcription reagents, RNasin ribonuclease inhibitor, RNase A and nuclease-treated rabbit reticulocyte lysate were purchased from Promega. Easytag L-[
35 S]methionine/ cysteine was obtained from PerkinElmer Life Sciences. The crosslinking reagent, BMH (bismaleimidohexane), was purchased from Perbio Science. All other chemical reagents were obtained from Sigma Chemical and Merck. Reagents for cell culture were purchased from Invitrogen. The mouse monoclonal anti-HA (haemagglutinin) antibody was a gift from Dr I. Hagan (Paterson Laboratories, Manchester, U.K.), and the rabbit polyclonal antibodies specific for the Sec61α and Sec61β subunits were kindly provided by Professor R. Zimmermann (Department of Medical Biochemistry and Molecular Biology, University of Saarland, Saarland, Germany) and Professor B. Dobberstein (Zentrum für Molekulare Biologie, University of Heidelberg, Heidelberg, Germany). The mouse monoclonal antibody specific for the Nterminal region of bovine opsin was purified from a hybridoma line originally supplied by Dr P. Hargrave (Department of Ophthalmology, University of Florida, Gainesville, FL, U.S.A.) [29] .
Opsin constructs
Single or double cysteine residues were introduced using the QuikChange ® site-directed mutagenesis kit (Stratagene) into a cysteine-null version of bovine opsin previously described [16] . The OPN/5-7 [OPN (N-terminal region of opsin) fused to TM segments [5] [6] [7] construct was generated by the deletion of residues to give a polypeptide with opsin residues 1-35 fused with residues 195-348. For the extension of OPN/5-7 nascent chain beyond the last residue of opsin, the C-terminus of OPN/5-7 was PCR spliced with residues 31-220 of bovine PPL (preprolactin) and cloned into the PCR-SCRIPT vector (Stratagene) downstream of a T7 promoter. This was followed by the introduction of single cysteine residues at specified locations. The deletion of TM5 and TM6 to generate the OPN/TM7PPL construct was carried out using the ExSite mutagenesis kit according to the manufacturer's protocol (Stratagene). The replacement of TM7 with TM3 to generate the OPN/TM3PPL construct was completed using the QuikChange ® site-directed mutagenesis kit (Stratagene). The replacement in TM7 with TM3 in the OPN/5-7-PPL construct to generate OPN/TM5,6,3PPL was also completed using the QuikChange ® kit.
In vitro transcription and translation
mRNA was obtained by performing in vitro transcription with T7 RNA polymerase (Promega) as described by the manufacturer and purified using an RNeasy Mini Kit (Qiagen). In all experiments, digitonin-permeabilized cultured HT1080 fibroblasts (European Collection of Cell Cultures, Salisbury, U.K.) [30] were used as a source of ER membranes. In vitro translation of the mRNA chains was carried out in a rabbit reticulocyte lysate system (Promega) for 15 min at 30
• C in the presence of [
35 S]methionine/cysteine (0.82 µCi/µl) and semi-intact HT1080 cells. Initiation of translation was subsequently inhibited by the addition of 0.1 mM aurintricarboxylic acid for 10 min at 30 • C. Cycloheximide to 2 mM was added to terminate translation reactions and the samples were placed on ice for 5 min. Where nascent chains were released from the ribosome prior to crosslinking, samples were treated with 2 mM puromycin and 50 mM EDTA for 10 min at 30
• C in place of the cycloheximide treatment. The membrane fraction was isolated by centrifugation at 16 000 g for 30 s and washed twice in KHM buffer [110 mM potassium acetate, 20 mM Hepes and 2 mM magnesium acetate (pH 7.2)]. The final pellet was resuspended in KHM buffer for cross-linking reactions.
Cross-linking and immunoprecipitation
For cross-linking, 1 mM BMH (final concentration) was added to the membrane fraction and the mixture was incubated at 30
• C for 10 min. As the solvent control only DMSO was added. The cross-linking reaction was subsequently quenched with the addition of 2-mercaptoethanol to 5 mM final concentration and the samples were treated with 250 µg/ml RNase A at 37
• C for 5 min. Denaturing immunoprecipitations were then carried out as previously described [16] .
Endo H (endoglycosidase H) treatment
Immunoprecipitated samples on Protein A beads were denatured in Endo H-denaturing buffer (0.5 % SDS and 1 % 2-mercaptoethanol) for 30 min at 37
• C. Then 3 µl of 0.5 M sodium citrate (pH 5.5) buffer, 0.5 µl of 100 mM PMSF, 5.5 µl of H 2 O and 500 units of Endo H were added and the samples were incubated at 37
• C for another 30 min. The samples were solubilized in an equal volume of 2 × SDS sample buffer and resolved by SDS/PAGE. Opsin-derived nascent chains were immunoprecipitated using either a monoclonal antibody specific for the N-terminus of the polypeptide (Op), for the HA epitope on the C-terminus of the integration intermediates (HA) or with a non-related serum (NS). For each chain length, authentic doubly N-glycosylated opsin chains are indicated by < and their non-glycosylated counterparts by ᭺. Shorter opsin chains that lack the C-terminal HA epitope tag are indicated by * . Adducts to Sec61α and Sec61β were identified by immunoprecipitation with appropriate antisera (denoted α and β). P indicates adducts to an unidentified protein of ∼ 10 kDa, PAT-10 (lanes 9, 15, 21 and 27). Sec61α molecules produced by the translation of endogenous mRNA [24] are shown with ᭹. Vertical black lanes indicate sets of samples resolved on SDS/PAGE. Positions of molecular-mass markers (in kDa) are indicated to the left-hand side.
Sample analysis
Samples were solubilized in SDS/PAGE sample buffer at 37
• C for 30 min and resolved on 14 % Tris/glycine polyacrylamide gels. The resulting gels were fixed and dried before being exposed to a phosphoimager plate for visualization using Phosphor Imager FLA-3000 (Fuji). We imposed a strict criterion for authentic crosslinking adducts: the adduct should be clearly immunoprecipitated by both the α-opsin antiserum, which recognizes the N-terminus of the opsin chain, and the α-HA antiserum, which recognizes the HA-epitope tag at the C-terminus. Identification of the crosslinking partner can then be achieved by immunoprecipitation of the adduct with antisera specific to translocon components. This allows true adducts to nascent chains with an intact N-and Cterminus to be distinguished from other products which may be formed with truncated opsin chains [24] .
RESULTS
Our previous studies of opsin biosynthesis have primarily focused on the molecular environment of an N-terminal region of opsin, comprising TM segments 1-3, during its integration into the ER membrane [16, 24, 25] . In the present study, we extend this work to examine the integration of the remainder of the opsin polypeptide incorporating TM segments 4-7. Site-specific crosslinking was employed to analyse the molecular environment of each TM segment using integration intermediates of increasing chain lengths to represent different stages of opsin biosynthesis (c.f. [24] ). These integration intermediates can be generated by the translation of truncated mRNAs that lack a stop codon, thus preventing the release of the polypeptide chain from the ribosome [31] . As a consequence, the polypeptide chains are lodged at the ER translocon and may only be released by the removal of the ribosome, for example by puromycin treatment [31] . During our previous studies, we have found that the interpretation of the crosslinking patterns obtained using such integration intermediates can be complicated by the presence of a heterologous population of nascent chains, most likely as a consequence of ribosome stacking on the truncated mRNA [16, 24] . Therefore an HA epitope tag was introduced at the C-terminus of each integration intermediate to confirm the authenticity of specific adducts [24] . For each of the opsin TM segments analysed below, two or more locations for single cysteine probes were initially tested. The probe position generating the clearest adducts with known components of the Sec61 complex was then selected for detailed analysis (results not shown).
TM4 associates transiently with the translocon during opsin biosynthesis
Building on our previous studies, a single cysteine probe was introduced at position 154 within TM4 and a range of integration intermediates from a chain length of 204 residues, at which stage TM4 is predicted to be capable of engaging the ER translocon, to the full length opsin polypeptide (348 residues plus a 9 residue C-terminal HA tag) were generated ( Figure 1 ). Crosslinking was performed with a homobifunctional, sulfhydrylspecific cross-linking reagent BMH, and adducts to subunits of the ER translocon were identified using anti-sera against the Sec61 components, Sec61α and Sec61β. As previously seen, when longer opsin-derived polypeptides were analysed, the population of nascent chains generated was heterogeneous and some species lacked an intact C-terminus [24] . Hence we observed differential recognition of translation products by antisera specific to the Nand C-termini of the polypeptide ( When the nascent chain was 259 residues long, TM4 was cross-linked to a ∼ 10 kDa protein that was distinct from Sec61β ( Figure 1 , lane 9, indicated by P), and this adduct was also observed at longer chain lengths ( Figure 1 , lanes 15, 21 and 27, products indicated by P and P?). Although significantly weaker than previously described, these adducts bear a clear resemblance to the previously described ∼ 10 kDa protein, PAT-10 [16, 24] . Taken together, these data suggest that TM4 enters the Sec61 complex when the nascent chain is 204 residues long but has fully exited the translocon and is most likely in the vicinity of the PAT-10 component at a chain length of 259 residues and beyond. Significantly, a 259 residue opsin chain is predicted to represent a stage of biosynthesis at which TM5 would engage the Sec61 translocon ( Figure 1 , OP259 cartoon).
TM5 is adjacent to PAT-10 throughout its integration
In order to analyse the integration of the more C-terminal TM domains of opsin, long integration intermediates have to be generated, and such intermediates often form cross-linking adducts that are weak and diffuse [16, 24] , with significantly more incomplete chains lacking the C-terminal HA tag (see Figure 1 , compare lanes 26 and 27, products indicated by *). Hence the results from the cross-linking analysis of such long intermediates can be ambiguous. In order to verify the analysis of cross-linking products obtained using probes located in opsin TM5 to TM7, a shorter version of the opsin polypeptide chain was generated. We noted that residues 195-348 of opsin can be expressed and folded independently of the N-terminal portion [32] . Hence the first 35 residues of opsin containing the two N-glycosylation sites were fused to this C-terminal portion of opsin, comprising TM5-TM7, to generate the artificial OPN/5-7 polypeptide chain (Figure 2A ). This allowed shorter integration intermediates to be generated for the analysis of TM5, TM6 and TM7 insertion.
The topology of the OPN/5-7 nascent chains ( Figure 2B ) was first ascertained by ensuring that all cross-linking adducts were formed with OPN/5-7 integration intermediates which were doubly N-glycosylated. A cysteine probe was introduced at residue 70 (equivalent to residue 229 in the full-length opsin polypeptide chain) at the C-terminal boundary of TM5 (OPN/5-7 100[cys70]), and BMH-mediated cross-linking performed Figure 2C, compare lanes 1 and 6) , and formed adducts with Sec61α and a ∼ 21 kDa putative ribosomal protein [25] that were also both Endo H sensitive ( Figure 2C , compare lanes 2-4 and lanes 7-9, indicated by α and x). This behaviour confirmed that the OPN/5-7 integration intermediates were correctly glycosylated and authentically oriented at the ER translocon ( Figure 2C ).
In the context of the OPN/5-7 chains, TM5 is now the first TM domain, TM6 the second and TM7 the third. In order to ensure that the cross-linking results observed were representative of the molecular environment of TM5, TM6 and TM7 in their original position within full-length opsin, a cross-linking analysis with authentic opsin integration intermediates was , the cysteine residue is in the same relative position in the TM segment in both constructs, and the TM segment is the same distance away from the ribosome in both cases. The OPN/5-7 construct was also further extended in length by splicing the soluble region from bovine PPL on to the C-terminus of the opsin chain, thus enabling the chain length to be extended up to 229 and 280 residues (lanes 21-30). Putative adducts with Sec61α and Sec61β are labelled with 'α?' and 'β?' respectively. Two unidentified adducts are indicated with 'X' for an adduct potentially with a ribosomal subunit [16] and a 'Y'; all other symbols are as defined previously.
performed for comparison. Hence opsin integration intermediates of increasing chain lengths were subjected to a cross-linking analysis and adducts with translocon components were examined. OP259[cys229] gave adducts to both Sec61α and Sec61β ( Figure 3A , lanes 2-6, indicated by α and β), suggesting that TM5 had engaged the translocon at this stage. A currently unidentified adduct of ∼ 21 kDa was also apparent on crosslinking with OP259[cys229] ( Figure 3A , lanes 2 and 3, indicated by X), which may represent a ribosomal subunit [16] . When longer nascent chains were examined (OP304 to OP357), adducts to translocon components could be observed, but as the chain length increased it became difficult to be confident that these products were immunoprecipitated with the α-HA antiserum and therefore represented adducts with authentic integration intermediates ( Figure 3A, lanes 20-24, indicated by α? and β? ).
In contrast with the adducts with the Sec61 subunits, very distinct adducts with a ∼ 10 kDa component were seen with integration intermediates of 304 residues in length and beyond ( Figure 3A,  lanes 9, 15 and 21) . These adducts bore a striking resemblance to products previously observed when cross-linking from a probe in TM1 [16] , and we concluded that TM5 most likely has a strong association with a PAT-10-like protein during its integration.
When cross-linking analysis was performed for the equivalent OPN/5-7 nascent chains, authentic adducts obtained with translocon components could be more readily distinguished ( Figure 3B ). Adducts to Sec61α and, at chain lengths of 145 residues and beyond, PAT-10 were observed and these adducts were clearly recognized by the α-HA antibody ( Figure 3B , lanes 2-4, 7-9, 12-14 and 17-19, indicated by α and P). Although OPN/5-7 100[cys70] gave a clear adduct with Sec61β ( Figure 3B , lane 5), at longer chain lengths it was difficult to authenticate the Sec61β adduct by immunoprecipitation with the α-HA antibody due the presence of the much stronger PAT-10 product with a similar molecular mass ( Figure 3B , compare lanes 10, 15 and 20, indicated by β). Since adduct formation with Sec61α persisted until the nascent chain reached the equivalent of full length (OP198), this indicated that TM5 most likely remained associated with the ER translocon until protein synthesis was complete.
The extended association of opsin TM5 with the Sec61 complex may reflect its specific recognition and retention by the ER translocon. Alternatively, TM5 may remain adjacent to the translocon because the polypeptide tether to the ribosome is simply too short for its complete release from the Sec61 complex to occur. In order to distinguish between these two possibilities, the C-terminus of the OPN/5-7 polypeptide chain was artificially extended with a hydrophilic tail taken from residues 31-220 of bovine PPL, generating OPN/5-7-PPL 229[cys70] and OPN/5-7-PPL 280[cys70]. When these polypeptides were analysed by cross-linking, authentic adducts with both Sec61α and PAT-10 were observed ( Figure 3B, lanes 22-25 and 27-30 ). Taken as a whole, these results suggest that TM5 remains associated with the ER translocon throughout nascent chain synthesis and that this association persists even when the chain is artificially extended. In addition, TM5 appears to encounter PAT-10 after it moves away from Sec61α, and it remains associated with PAT-10 throughout opsin nascent chain synthesis.
The opsin nascent chain is adjacent to a single PAT-10 molecule during biosynthesis
A distinctive feature of TM1 integration is its association with a novel ∼ 10 kDa protein, PAT-10, that is observed as soon as TM2 enters the ER translocon and that remains as long as the polypeptide is ribosome associated [16, 24] . Although no crosslinking to PAT-10 from TM2 or TM3 has been observed [24] , we find that TM5, and to a much lesser extent TM4, exhibit discrete adduct formation extremely consistent with the partner being PAT-10. Hence, as previously observed for the association of TM1 with PAT-10 [24] , these adducts are observed only after the subsequent TM segment has been synthesized (see Figures 1  and 3A ) and they persist until the end of polypeptide synthesis. In order to determine whether the opsin protein interacts with multiple copies of PAT-10, two cysteine probes, one in TM1 (Cys 56 ) and the other flanking TM5 (Cys 229 ), were introduced into an OP304 integration intermediate. OP304 was the shortest integration intermediate that would permit both TM1 and TM5 to form cross-linking adducts with PAT-10 (see Figure 3A , lane 9 and Figure 4 , lane 3, indicated by P). This approach has been successfully used previously to insert cysteine probes into both TM1 and TM3, to allow simultaneous cross-linking to PAT-10 and Sec61β respectively [24] .
Cross-linking analysis of OP304[cys56,229] generated a single major product which corresponds to the polypeptide chain being cross-linked to only one copy of PAT-10 ( Figure 4 , lane 6, indicated by P). No obvious higher molecular mass adducts were observed, as would be predicted if TM1 and TM5 were each crosslinked to different ∼ 10 kDa components. We therefore concluded that TM segments 1 and 5 are most likely to be adjacent to the same PAT-10 molecule during opsin biosynthesis.
TM6 remains associated with the translocon throughout opsin biosynthesis
The molecular environment of opsin TM6 was examined using nascent opsin chains with a single cysteine residue at position 275 near the C-terminal end of the TM segment. Integration intermediates of chain lengths 304, 339 and 357 residues of the opsin polypeptide chain were generated and examined by site-specific cross-linking ( Figure 5A ). The shortest integration intermediate, OP304
[cys275], gave a discrete adduct with Sec61β, indicating that TM6 had engaged the translocon at this stage ( Figure 5A, lanes 2-6, indicated by β) . When the nascent chain reached 339 residues, TM6 formed adducts with both Sec61α and Sec61β ( Figure 5A , lanes 8-12, indicated by α and β) and these interactions appeared to be maintained until the nascent chain reached full length at 357 residues, although as previously discussed, the authenticity of adducts formed with longer opsin chain lengths was less definitive ( Figure 5A , lanes 14-18, indicated by α? and β?).
In order to authenticate these adducts, a parallel cross-linking analysis was performed with the OPN/5-7 polypeptide chain ( Figure 5B ). When the equivalent integration intermediates were analysed, a similar pattern of adduct formation was observed. OPN/5-7 145[cys116] gave a distinct adduct to Sec61β ( Figure 5B, lanes 2-5, indicated by β Figure 5B , lanes 7-10 and 12-15, indicated by α and β). These results indicated that opsin TM6 in the OPN/5-7 polypeptide chain had engaged the Sec61 complex when the nascent chain was 145 residues long and it remains associated with the translocon throughout synthesis.
In order to examine further the nature of the association between opsin TM6 and the Sec61 complex, the polypeptide chain tether was further extended to generate OPN/5-7-PPL 229[cys116] and OPN/5-7-PPL 280[cys116]. Cross-linking of these nascent chains generated adducts with Sec61α ( Figure 5B , lanes 17-20 and 22-25, indicated by α) consistent with opsin TM6 remaining in close proximity to the Sec61 complex even when TM7 has been fully synthesized and the C-terminus of the polypeptide artificially extended.
TM7 engages the translocon throughout opsin biosynthesis
In order to examine the integration of the final opsin TM segment, TM7, cross-linking was performed using integration In addition, adducts with Sec61α were clearly identified for these nascent chains ( Figure 6B, lanes 2-4 and 7-9, indicated by α) . As with the analysis of opsin TM5 and TM6, two additional integration intermediates with extended chain lengths were examined in order to determine whether TM7 could exit the translocon completely when the polypeptide tether was lengthened. The integration intermediates OPN/5-7-PPL 229[cys128] and OPN/5-7-PPL 280[cys128] both produced adducts with Sec61α and Sec61β ( Figure 6B, lanes 12-15 and 17-19, indicated by α and β) . The adducts with Sec61α and Sec61β observed at the longest length of 280 residues ( Figure 6B , lanes 17-20, indicated by α and β) were not present when integration intermediates were treated with puromycin to release the opsin polypeptide chains from the ribosome and enable complete integration and exit from the Sec61 translocon prior to cross-linking ( Figure 6B, lanes 22-25) . Opsin TM7 therefore remained associated with the Sec61 translocon well beyond the maximum chain length for wild-type opsin and is only fully integrated into the ER membrane after artificial termination of translation
Retention at the Sec61 translocon is TM-specific
The prolonged retention of opsin TM7 at the ER translocon may either reflect the intrinsic properties of the TM segment itself or may alternatively be a consequence of its relative position as the final TM segment of opsin to encounter the translocon. In order to try and distinguish between these two possibilities, we initially attempted to analyse the membrane integration of opsin TM7 alone without any other opsin TMs being present. However, we found that opsin TM7 is an extremely poor ER targeting signal, as has been previously suggested [33] , and were unable to pursue this approach (results not shown).
We therefore devised an alternative approach to establish the basis for the retention of TM7 at the Sec61 translocon by replacing it with an alternative TM domain within the context of the OPN/5-7-PPL construct. On the basis of its rapid exit from the ER translocon [24] , we identified opsin TM3 as a good candidate to replace TM7. Our previous study had analysed the authentic opsin polypeptide and we first established whether TM3 was able to efficiently exit the Sec61 translocon in isolation. To this end, OPN/TM3PPL was generated comprising the opsin N-terminal region with two sites for N-glycosylation, TM3 of opsin, the C-terminal cytoplasmic tail of opsin, and finally a large segment of PPL to allow artificially long integration intermediates to be generated (see Supplementary Figure 1A at http://www.BiochemJ.org/bj/411/bj4110495add.htm). When analysed in vitro, OPN/TM3PPL is efficiently glycosylated at all chain lengths tested (see Supplementary Figure 1B, lanes  1-3, 6-8, 11-13 and 16-18, open arrowhead) and on the basis of a careful cross-linking analysis we concluded that TM3 is efficiently partitioned into the lipid phase of the ER membrane (see Supplementary Figure 1B) , as indicated by our previous studies on early events in the biosynthesis and integration of opsin [24] .
Having demonstrated the intrinsic capacity of opsin TM3 to efficiently exit the Sec61 translocon, both in its 'native' location between TM2 and TM4 [24] and also in isolation from other opsin TM regions (see Supplementary Figure 1) , we now wanted to test the behaviour of TM3 when it was used to replace TM7 in the OPN/5-7-PPL polypeptide. The OPN/TM5,6,3-PPL construct was therefore generated ( Figure 7A) , and crosslinking was performed from a single cysteine at residue 135, equivalent to residue 115 in full-length opsin [24] and residue 44 in OPN/TM3PPL (see Supplementary Figure 1 Figure 7B, lanes 11-15) . We therefore conclude that the prolonged association of TM7 with the Sec61 translocon is not due to its location as the final TM domain within the polypeptide chain.
DISCUSSION
We have used site-specific chemical cross-linking to characterize the molecular environment of TM4 to TM7 of opsin during its biosynthesis in order to study how different TM regions are accommodated by the Sec61 translocon during ER integration. By using immunoprecipitation from both the N-and C-termini of the nascent polypeptide chains, we can identify adducts with defined integration intermediates [16, 24] . Thiol-specific, homobifunctional cross-linking reagents such as BMH, have been successfully applied to the study of protein biosynthesis at the ER [25] and the mitochondrion [34] . When combined with the use of engineered single cysteine residues these reagents provide a platform for a site-specific analysis of the environment of individual TM segments at defined stages of biosynthesis [16, 24] . However, this technique can only identify components adjacent to the nascent polypeptide that contain an accessible cysteine. This means that, in the context of the data in the present study, any loss of adduct formation observed upon increasing the length of the nascent opsin chain may in principal reflect either a lateral exit of the TM segment into the lipid bilayer and away from the ER translocon site, or a conformational change that renders one or more cysteine residues inaccessible. In practice, a loss of cross-linking to the Sec61 complex is considered to be a reliable report of TM segment integration when either a thiol-mediated approach, or less restricted photocross-linking techniques, are exploited [16, 18, 19, 21, 23, 24, 26, 35] .
Unlike the synchronized integration of TM1 to TM3 [24] , we find that opsin TM4 engages the Sec61 complex in a relatively straightforward manner as TM3 departs and is itself subsequently 'displaced' as TM5 emerges from the ribosome. In contrast, TM5 remains in close proximity to the ER translocon until the entire opsin polypeptide chain is synthesized. A further level of complexity with regard to the analysis of TM5 is that long integration intermediates have to be analysed, and such chains [5] . Only the α and β subunits are represented since these are the cross-linking partners of the opsin integration intermediates studied, while the PAT-10 protein is as described previously [16, 24] . The relative location of each opsin TM segment (numbered circle) is indicated at different stages of the integration process as deduced from the cross-linking patterns of specific integration intermediates. TM4 is part of an N-terminal independently folding sub-domain of opsin and rapidly exits the Sec61 complex (i-iii). TM segments 5-7, which can form a C-terminal independently folding subdomain, remain associated with the translocon (ii-iv) until biosynthesis is complete (v). Results for TM segments 1-3 (broken circles) have been generated previously [24] . Both opsin TM1 and TM5 exhibit a pronounced and prolonged association with PAT-10, suggesting a co-ordination step during the biosynthesis of opsin in which two folding subdomains (TM segments 1-4 and TM segments 5-7) are integrated independently. PAT-10 may contribute directly to the regulation of this distinct, and substrate-specific, membrane integration process.
generally give low efficiency adducts that can be difficult to unambiguously confirm as being authentic. To validate such crosslinking data, a shortened construct containing only the N-terminal region and TM5 to TM7 of opsin (OPN/5-7) was generated. Since the relative positions of TM segments were altered, i.e. TM5 becomes the first TM segment etc., the resulting data should be interpreted carefully. Hence, wherever feasible, any crosslinking data obtained using OPN/5-7 was compared with that from equivalent authentic opsin intermediates. This approach allowed an unambiguous assignment of the cross-linking data obtained.
When analysed in this way, a striking feature of TM5 is its constant association with the Sec61 complex throughout nascent chain synthesis. This association was apparent with both authentic opsin and OPN/5-7, and suggests that, unlike TMs 1-4 [16, 24 and the present study], TM5 remains associated with the ER translocon until the complete opsin chain is synthesized. This behaviour is clearly significant and implies that the Sec61 complex can distinguish between different TM segments and may regulate their release into the ER membrane. The distinct association of different opsin TM segments with the ER translocon also supports the idea that TM regions display sequence-dependent interactions with the Sec61 complex [19] . As for TM5, the environment of TM6 and TM7 was examined using both authentic opsin chains, and the shorter OPN/5-7 derivatives. In both of these contexts, TM6 was found associated with the Sec61 complex from the shortest integration intermediate examined to the full-length polypeptide chain, indicating that TM6 engages the translocon for a prolonged period of time. Like TM6, the cross-linking pattern of TM7 in the context of both authentic opsin and OPN/5-7-derived chains showed that TM7 also remains at the translocon throughout nascent chain synthesis. Even when integration intermediates were artificially extended by the addition of the PPL polypeptide at the C-terminus (OPN/5-7-PPL), TM segments 5, 6 and 7 remained associated with the translocon. The loss of cross-linking between opsin TM segments 4-7 and the Sec61β subunit detected upon chain extension are entirely consistent with the relocation of these TMs within the Sec61 complex during biosynthesis, as previously suggested ( [16, 24] and see Figure 8 ).
Another striking feature of opsin TM5 is its strong adduct formation with PAT-10, akin to that previously observed with TM1 [24] . Although it is a formal possibility that TM5 is cross-linked to a different ∼ 10 kDa component, we consider this unlikely, particularly since only one adduct with a ∼ 10 kDa protein was observed when cross-linking was performed with opsin chains containing two cysteine residues capable of adduct formation with PAT-10, one in TM1 and the other in TM5. Furthermore, TM5 forms clear adducts with PAT-10 when we analyse authentic opsin nascent chains, ruling out an artificial association with OPN/5-7. We previously suggested that PAT-10 may be an accessory factor or 'TM chaperone' that functions to regulate the release of specific TM segments from the ER translocon into the membrane [16] . Intriguingly, in our present study we observe a prolonged association of PAT-10 with TM1 and TM5, each of which represent the first TM segment of two well-characterized opsin subdomains capable of independent folding and assembly [32, 36] . Hence we propose that PAT-10 may co-ordinate the exit of biosynthetically distinct subdomains of polytopic membrane proteins such as opsin ( Figure 8 ). As for TRAM [19, 37] , the location of PAT-10 at the translocon periphery [16, 24] supports a model where TM segment integration into the ER membrane is a highly regulated process (see Figure 8) .
The extended interaction between opsin TM segments 5-7 and the Sec61 complex led us to investigate the basis for TM7 retention. As previously described [33] , we were unable to analyse TM7 alone (results not shown), most likely because it is the shortest and least hydrophobic transmembrane helix in opsin [38, 39] . In contrast, when TM3 was studied in isolation, using OPN/TM3PPL (see Supplementary Figure 1A) , the resulting integration intermediates were efficiently glycosylated at all chain lengths tested, and cross-linking showed that TM3 rapidly exited the ER translocon upon chain extension. Most significantly, when TM7 was replaced with TM3 to generate OPN/TM5,6,3-PPL, the behaviour of the final TM region was altered substantially, with TM3 clearly exiting the translocon at a much earlier stage of biosynthesis. Hence, it is the properties of the TM segment and not its relative location within the polypeptide chain that result in the prolonged association of opsin TM7 with the ER translocon (Figure 8 ).
The clear distinction in the behaviour of opsin TM3 and TM7 at the ER translocon correlates well with previous biophysical studies that demonstrate the importance of amino acid hydrophobicity during the partitioning of TM helices into the lipid phase of the ER membrane [20] . On the basis of this study we conclude that it is the Sec61 complex, together with accessory factors, that directly determines the individual fate of specific TM segments. The retention of the weakly hydrophobic TM7 in the translocon compared with the rapid lateral exit of TM3 into the ER membrane supports a model in which nascent TM segments entering the ER translocon may be rapidly released or selectively retained depending upon their specific properties and assembly requirements. Given the function of the Sec61 complex as a molecular machine that introduces specific polypeptide regions into a phospholipid bilayer, one can rationalize the need for it to be equipped to deal with non-optimal TM segments. In the case of opsin TM7, hydrophobicity must be significantly compromised by the presence of Lys 296 , which is critical for chromophore attachment and consequently biological function [38, 39] . Hence the release of opsin TM7 from the translocon is most likely to be contingent upon the remainder of the polypeptide assuming a suitable conformation to accommodate it ( Figure 8 ).
In summary, our detailed analysis of opsin biogenesis supports a model where the ER translocon specifically regulates the integration of the TM segments within a polytopic membrane protein so as to accommodate the folding and functional requirements of the substrate itself. Hence the selective retention of multiple TM domains at distinct sites within the translocon may be required in order to allow the correct assembly of complex polytopic proteins [24, 26] . The further consolidation of this model will require a detailed analysis of several different precursors, and a greater structural understanding of the active ER translocon.
